🇺🇸 FDA
Pipeline program

Methylphenidate

INDICES-WP2-2

Approved small_molecule completed

Quick answer

Methylphenidate for Carboxylesterase 1 (CES1) Genotype is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Carboxylesterase 1 (CES1) Genotype
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials